Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Process Outlined for Preparing Non-Androgel Bellwether Trials in MDL December 29, 2014 Austin Kirk Add Your Comments The U.S. District Judge presiding over all federal testosterone lawsuits has outlined a case management plan for preparing a group of claims for early trial dates in the federal court system that do not involve use of AbbVie’s market-leading “Low T” drug AndroGel. Since June 2014, all product liability lawsuits filed in U.S. District Courts throughout the country involving heart attacks and other injuries associated with side effects of testosterone replacement therapy have been centralized before U.S. District Judge Matthew Kennelly in the Northern District of Illinois as part of a federal MDL, or multidistrict litigation. There are currently at least 274 Androgel lawsuits, Axiron lawsuits, Testim lawsuits, Androderm lawsuits, Depo-Testosterone lawsuits and other related claims pending before Judge Kennelly. However, it is ultimately expected that several thousand complaints will be involved in the litigation. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The vast majority of the claims currently pending in the MDL involve use of AbbVie’s Androgel product, which is the most widely used testosterone treatment on the market. As a result of the more advanced status of the AbbVie lawsuits, Judge Kennelly previously established a process for preparing a small group of AndroGel cases for early trial dates, which are expected to begin between October 2016 and April 2017. In a case management order (PDF) issued on December 19, Judge Kennelly indicates that another group of cases pending against Auxilium, Eli Lilly, Actavis, Watson Laboratories, Pfizer and Endo Pharmaceuticals will be prepared for bellwether trials, involving products made by these other low-T drug manufacturers. While the first Androgel trials are expected to begin by late 2016, it does not appear likely that this second round of non-AbbVie cases will go before a jury until at least mid-2017. The parties have been directed to meet by September 10, 2015 regarding a process for selecting the cases that will go through this bellwether process and proposing trial dates. According to the Order, Plaintiffs have advise the court that they contemplate the trial dates to be proposed will include an initial trial involving Auxilium, which is the manufacturer of Testim gel. Testosterone Litigation The federal Testosteorne MDL was established to reduce duplicative discovery into common issues in cases filed in U.S. District Courts nationwide, as well as to avoid conflicting pretrial orders from different judges and to serve the convenience of the parties, witnesses and the courts. All of the lawsuits involve similar claims that men suffered a heart attack, stroke, deep vein thrombosis, pulmonary embolism or other cardiovascular injury after using a low T drug, alleging that the manufacturers failed to adequately warn users and the medical community. In complex pharmaceutical litigation, where a large number of lawsuits are filed over injuries caused by similar products, it is common for a small group of cases to be selected for early trial dates, known as “bellwether” lawsuits. While the outcomes of these early trial dates are not binding on other claims, they are designed to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the cases. Following a pretrial proceedings and a series of bellwether trials, if testosterone settlements are not reached by the drug makers, Judge Kennelly may begin remanding cases back to U.S. District Courts throughout the country for individual trial dates. Tags: Androderm, AndroGel, Axiron, Depo-Testosterone, Heart Attack, Testim, Testosterone Image Credit: | More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)